戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                             %ucOC values were compared with 140 healthy subjects aged
2                              In substudy A, %ucOC decreased with phylloquinone supplementation (P < 0
3             Changes in serum osteocalcin and ucOC are associated with an improvement in insulin secre
4  concentrations were higher (P < 0.001) and %ucOC values were lower (P = 0.001) after the broccoli an
5  osteocalcin concentrations (P < 0.05), and %ucOC was positively associated with NTx and bone-specifi
6 cant difference in plasma phylloquinone and %ucOC between the 2 groups after either the broccoli or o
7                              In substudy B, %ucOC decreased in all supplemented groups by week 1 (P f
8                     Concomitantly, baseline %ucOC was highest in the young and lowest in the old men
9     Phylloquinone supplementation decreased %ucOC dose-dependently; %ucOC was significantly different
10 mentation decreased %ucOC dose-dependently; %ucOC was significantly different between the 250- micro
11               Subjects with CF had a higher %ucOC with low [45% (10%, 76%)] and medium [41% (3%, 66%)
12  Despite a decrease of approximately 200% in ucOC concentrations, HOMA-IR was similar in the 2 groups
13                                   Changes in ucOC concentrations do not alter glucose metabolism in w
14             We determined whether changes in ucOC concentrations in humans were associated with chang
15 % CI: 0.23, 5.52; P = 0.033), and changes in ucOC were linked to a decrease in HOMA-IR (beta coeffici
16 n secretion and action despite reductions in ucOC concentrations.
17 K status (high plasma phylloquinone and low %ucOC) was associated with lower bone resorption and form
18         Among all supplemented groups, mean %ucOC decreased from 7.6% to 3.4% without significant dif
19 hylloquinone concentration and percentage of ucOC) did not change significantly in response to the su
20        Under-gamma-carboxylated osteocalcin (ucOC) increases insulin secretion and decreases glucose
21         Serum undercarboxylated osteocalcin (ucOC) and total osteocalcin, N:-telopeptides of type I c
22 percentage of undercarboxylated osteocalcin (ucOC), was determined in 38 men and women with rheumatoi
23 teocalcin and undercarboxylated osteocalcin (ucOC)], plasma phylloquinone, urinary gamma-carboxygluta
24 ercentage of undercarboxylated osteocalcin (%ucOC) was measured at baseline and weeks 1 and 2.
25 entage serum undercarboxylated osteocalcin (%ucOC), and urinary gamma-carboxyglutamic acid in respons
26 ercentage of undercarboxylated osteocalcin (%ucOC)] and IL-6, osteoprotegerin, and C-reactive protein
27 ercentage of undercarboxylated osteocalcin (%ucOC)] was measured at baseline in a study of 245 health
28                     Total serum osteocalcin, ucOC, glucose, and insulin concentrations were measured
29 placebo or phylloquinone, total osteocalcin, ucOC, glucose, and insulin concentrations and HOMA-IR (1
30 e were no alterations in total or percentage ucOC concentrations during the phylloquinone-restricted
31     In subjects with CF, the median (range) %ucOC was 35% (3%, 76%) and the median (range) for PIVKA-
32                               At 6 mo, serum ucOC concentrations in the experimental group were 0.96
33                              At 12 mo, serum ucOC concentrations were 0.92 +/- 0.09 ng/mL and 3.13 +/
34 associated with IL-6 and CRP, whereas serum %ucOC was inversely associated with IL-6.
35 (HOMA-IR) was calculated and correlated with ucOC concentrations.
36 ith plasma phylloquinone and inversely with %ucOC.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。